Drugs / Budesonid
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT02988778 | Oct 2019 | perennial allergic rhinitis | Eurofarma Laboratorios S.A. | Withdrawn | No outcome recorded Stop: Business |
Evidence & citations 4 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Budesonid | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02988778 ↗ |
| Known as | Busonid | “Budesonid 50mcg (Busonid)” NCT02988778 ↗ |
| Known as | Noex | “Budesonid 50mcg (Noex)” NCT02988778 ↗ |
| Route | Intranasal | “Suspention to nasal use” NCT02988778 ↗ |